“两票制”下中小型医药流通企业的法律风险与机遇

Legal Risks and Opportunities of Small and Medium-sized Pharmaceutical Circulation Enterprises under the "Two-vote System"

自药品采购行业推行“两票制”以来,医药流通行业集中度提高、运营成本增大、利润空间压缩,给其中的中小型企业的法律风险防控带来巨大的压力和挑战。文章重点关注了此类影响,针对其股权、财务、管理等方面存在的法律风险提出了对策和建议,并分析了新机遇。

Since the implementation of the "two-vote system" in drug procurement industry by the government, increased concentration, increased operating costs and reduced profit in the pharmaceutical circulation industry will bring tremendous pressure and challenges to the legal risk prevention and control insmall and medium sized pharma. ceutical circulation enterprises. This paper focuses on the impact of "two-vote system" on small and medium sized pharmaceutical circulation enterprises, puts forward countermeasures and suggestions for the legal risks existing in equity, finance and management, and analyzes new opportunities for small and mediumsized pharmaceutical circula. tion enterprises under the "two-vote system".